Related references
Note: Only part of the references are listed.Emerging and critical issues in the pathogenesis of lupus
Mariele Gatto et al.
AUTOIMMUNITY REVIEWS (2013)
Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus
Leomar D. C. Lyrio et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment
M. Bijl et al.
AUTOIMMUNITY REVIEWS (2012)
Systemic lupus erythematosus one disease or many?
N. Agmon-Levin et al.
AUTOIMMUNITY REVIEWS (2012)
Immune-mediated myelitis following hepatitis B vaccination
Joerg-Patrick Stuebgen
AUTOIMMUNITY REVIEWS (2012)
Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus
Faith M. Strickland et al.
JOURNAL OF AUTOIMMUNITY (2012)
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
C. Chao et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil
Lucija Tomljenovic et al.
JOURNAL OF LAW MEDICINE & ETHICS (2012)
Quantifying the efficacy of influenza vaccines
Alessandra Soriano et al.
LANCET INFECTIOUS DISEASES (2012)
Missense polymorphisms within IL-10R1 exons are not associated with systemic lupus erythematosus in Chinese
H. Cui et al.
LUPUS (2012)
Systemic lupus erythematosus following HPV immunization or infection?
H. F. Soldevilla et al.
LUPUS (2012)
Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations)
S. van Assen et al.
LUPUS (2012)
AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
Hanna Nohynek et al.
PLOS ONE (2012)
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
S. van Assen et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases
Carla G. S. Saad et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
HPV infection and cervical disease: A review
Jonathan R. Carter et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
'ASIA' - Autoimmune/inflammatory syndrome induced by adjuvants
Yehuda Shoenfeld et al.
JOURNAL OF AUTOIMMUNITY (2011)
Demyelinating disease and polyvalent human papilloma virus vaccination
Jason Chang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Guillain-Barre syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006-2009
Nizar Souayah et al.
VACCINE (2011)
SLE diagnosis and treatment: When early is early
Andrea Doria et al.
AUTOIMMUNITY REVIEWS (2010)
The new H1N1 and HPV vaccines and old fears
Ari Balofsky et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Are women with lupus at higher risk of HPV infection?
E. M. Klumb et al.
LUPUS (2010)
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention A pooled analysis of 11 clinical trials
Dominique Descamps et al.
HUMAN VACCINES (2009)
Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
Barbara A. Slade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
Darron R. Brown et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Ten cases of systemic lupus erythematosus related to hepatitis B vaccine
N. Agmon-Levin et al.
LUPUS (2009)
CNS demyelination and quadrivalent HPV vaccination
I. Sutton et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Vaccines and autoimmunity
Nancy Agmon-Levin et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Infections as triggers and complications of systemic lupus erythematosus
A. Doria et al.
AUTOIMMUNITY REVIEWS (2008)
Vaccination and autoimmune rheumatic diseases
Fabrizio Conti et al.
AUTOIMMUNITY REVIEWS (2008)
Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
Thomas Verstraeten et al.
VACCINE (2008)
Human papillomavirus infection and the development of cervical cancer and related genital neoplasias
Jorma Paavonen
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2007)
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ:: a combined analysis of four randomised clinical trials
L. Villa et al.
LANCET (2007)
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Suzanne M. Garland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Long-term prognosis and causes of death in systemic lupus erythematosus
Andrea Doria et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
DM Harper et al.
LANCET (2006)
Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control
EL Franco et al.
VACCINE (2005)
Share Paper
